Ticker Details
BridgeBio Pharma, Inc.
IPO Date:	June 24, 2019
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$13.06B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.88 | 3.00%
Avg Daily Range (30 D):	$2.07 | 2.73%
Avg Daily Range (90 D):	$1.49 | 2.12%

Institutional Daily Volume
Avg Daily Volume:	1.5M
Avg Daily Volume (30 D):	2.88M
Avg Daily Volume (90 D):	2.2M

Trade Size
Avg Trade Size (Sh.):	83
Avg Trade Size (Sh.) (30 D):	76
Avg Trade Size (Sh.) (90 D):	65

Institutional Trades
Total Institutional Trades:	7,868
Avg Institutional Trade:	$3.29M
Avg Institutional Trade (30 D):	$4.77M
Avg Institutional Trade (90 D):	$4.91M
Avg Institutional Trade Volume:	.09M
Avg Institutional Trades (Per Day):	5

Market Closing Trades
Avg Closing Trade:	$7.67M
Avg Closing Trade (30 D):	$23.71M
Avg Closing Trade (90 D):	$21.23M
Avg Closing Volume:	249.32K

News

Feb 22, 2026 @ 3:00 PM Blue Owl, Genuine Parts, And Okta Are Among Top 10... Source: Nabaparna Bhattacharya

Feb 17, 2026 @ 11:22 PM BridgeBio Pharma Reports Inducement Grants under N... Source: Na

Feb 12, 2026 @ 5:44 PM BridgeBio Nears 52-Week High On Strong Dwarfism Tr... Source: Vandana Singh

Dec 31, 2025 @ 3:01 PM How M&A Unlocked A Biotech Rebound In 2025—... Source: Namrata Sen

Nov 8, 2025 @ 3:41 PM Acoramidis Significantly Reduces All-cause Mortali... Source: Bridgebio Pharma

Financials
	TTM	Q2 2025	Q1 2025
Basic EPS	$-4.11	$-.95	$-.88
Diluted EPS	$-4.11	$-.95	$-.88
Revenue	$235.81M	$110.57M	$116.63M
Gross Profit	$226.84M	$106.91M	$113.99M
Net Income / Loss	$-785.01M	$-183.76M	$-169.61M
Operating Income / Loss	$-656.43M	$-134.28M	$-104.37M
Cost of Revenue	$8.97M	$3.65M	$2.64M
Net Cash Flow	$201.59M	$208.36M	$-140.5M
PE Ratio